Abbott (NYSE: ABT) today the FDA approved its CardioMEMS Hero next-generation pulmonary artery (PA) pressure reader.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results